Choosing an Antibiotic: Cidal vs Static, Empiric Therapy & PK/PD
A patient is dying of sepsis and there's no time to wait for the lab — so how does a doctor pick the right antibiotic out of dozens, right now? And once chosen, why must one drug be given as a single big daily dose while another is dripped continuously all day? These aren't arbitrary rituals. They flow from a few elegant rules about how antibiotics actually kill.
A feverish, confused patient is rushed in with sepsis — a life-threatening infection spreading through the blood. Cultures are drawn, but results will take a day or two, and the patient may not have hours. So the doctor makes an educated guess: which bacteria are the likely culprits given this illness, and which antibiotic covers them? A broad drug is started immediately. Days later, when the lab names the exact bug, the treatment is narrowed to the perfect fit. That two-step dance — guess well, then refine — is the heart of prescribing antibiotics.
Empiric first, then targeted
You often must treat before you know the bug. Because cultures take time, serious infections are first treated empirically — a best-guess antibiotic chosen from the likely pathogens for that site and patient, and local resistance patterns. Once the laboratory identifies the exact organism and tests which drugs kill it (the sensitivity report), the treatment is de-escalated to the narrowest effective agent. This 'start broad, then narrow' approach gives the sick patient immediate cover while protecting against needless resistance. Getting the empiric guess right depends on knowing which bugs typically cause which infections — the pattern-recognition that experienced clinicians live by.
Bactericidal vs bacteriostatic
Antibiotics divide into those that actively KILL bacteria (bactericidal — β-lactams, aminoglycosides, fluoroquinolones, vancomycin, metronidazole) and those that merely STOP them multiplying so the immune system can finish the job (bacteriostatic — tetracyclines, macrolides, clindamycin, sulfonamides). For most infections in a healthy person this distinction barely matters — a bacteriostatic drug plus a working immune system clears the infection fine. But it becomes critical when the patient can't help: in meningitis, endocarditis, or a severely immunocompromised patient, you want a bactericidal drug that finishes the bacteria itself rather than waiting for defences that may be absent or unable to reach the site.
How the dose is timed: PK/PD
Finally, HOW a drug kills decides how it's dosed. Some antibiotics are concentration-dependent: the higher the peak level, the more bacteria die — so aminoglycosides and fluoroquinolones are given as a single large daily dose to drive the peak high (which, for aminoglycosides, is also less toxic to the kidneys). Others are time-dependent: killing depends not on the peak but on how LONG the level stays above the threshold that inhibits the bug (the MIC) — so β-lactams work best given frequently, or even by continuous infusion, to keep the level up. Same goal, opposite dosing, all flowing from the killing curve.
- Empiric therapy = best-guess broad cover before cultures; then narrow to the identified bug.
- Bactericidal drugs kill; bacteriostatic drugs stop growth so immunity finishes the job.
- Prefer bactericidal in meningitis, endocarditis, and immunocompromised patients.
- Concentration-dependent (aminoglycosides, fluoroquinolones) → high single daily dose.
- Time-dependent (β-lactams) → dose frequently / continuously to stay above the MIC.
The once-daily aminoglycoside is a beautiful piece of pharmacology. Because these drugs are concentration-dependent, a single big daily dose maximizes the peak (better killing) AND, thanks to a 'post-antibiotic effect' where bacteria stay suppressed even after the level falls, lets the trough drop to near zero between doses — which gives the kidneys and ears a recovery window and lowers toxicity. One dose, better efficacy and less harm: the killing curve and the toxicity curve pointing the same way.
- Waiting for cultures in a septic patient. Start empiric therapy immediately, then de-escalate.
- Using a bacteriostatic drug in meningitis or endocarditis. Prefer a bactericidal agent.
- Dosing a time-dependent β-lactam too infrequently. Keep the level above the MIC.
- Never narrowing therapy once the organism is known. De-escalation curbs resistance.
Why are aminoglycosides given as one large dose per day rather than several small ones?
- Treat serious infections empirically first, then narrow once the organism is identified.
- Bactericidal kills; bacteriostatic stops growth — prefer cidal when immunity can't help.
- Concentration-dependent drugs → high once-daily dose; time-dependent → frequent/continuous.
- The MIC is the threshold at the centre of all antibiotic dosing.
- Katzung BG. Basic & Clinical Pharmacology — Clinical Use of Antimicrobials; PK/PD.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Principles of antimicrobial therapy.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Antibacterial drugs: principles of use.
- IDSA / sanford guide — Empiric therapy & antimicrobial stewardship.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Bactericidal vs bacteriostatic; dosing.
